[{"id":"c6bbab71-5678-4f57-b13f-81ebaa94a8e2","acronym":"","url":"https://clinicaltrials.gov/study/NCT03267173","created_at":"2021-01-18T16:08:14.684Z","updated_at":"2024-07-02T16:37:18.315Z","phase":"Phase 1","brief_title":"Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer.","source_id_and_acronym":"NCT03267173","lead_sponsor":"First Affiliated Hospital of Harbin Medical University","biomarkers":" HER-2 • PSCA","pipe":"","alterations":" ","tags":["HER-2 • PSCA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e mesothelin-targeted CAR-T immunotherapy"],"overall_status":"Unknown status","enrollment":" Enrollment 10","initiation":"Initiation: 06/15/2017","start_date":" 06/15/2017","primary_txt":" Primary completion: 06/01/2019","primary_completion_date":" 06/01/2019","study_txt":" Completion: 06/01/2019","study_completion_date":" 06/01/2019","last_update_posted":"2017-08-30"}]